Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program.

Azar, Rabih R; Ragy, Hany I; Kozan, Omer; El Khuri, Maurice; Bazergani, Nooshin; Marler, Sabrina; Teutsch, Christine; Ibrahim, Mohamed; Lip, Gregory Y H; Huisman, Menno V

Azar, Rabih R; Ragy, Hany I; Kozan, Omer; El Khuri, Maurice; Bazergani, Nooshin; Marler, Sabrina; Teutsch, Christine; Ibrahim, Mohamed; Lip, Gregory Y H; Huisman, Menno V.

Afiliação

Azar RR; Hôtel-Dieu de France, Saint-Joseph University, Beirut, Lebanon.
Ragy HI; National Heart Institute, Giza, Egypt.
Kozan O; Baskent University Medical Faculty, Istanbul, Turkey.
El Khuri M; American University of Beirut Medical Center, Beirut, Lebanon.
Bazergani N; Dubai Hospital, Dubai, United Arab Emirates.
Marler S; Boehringer Ingelheim Inc., Ridgefield, CT, USA.
Teutsch C; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Ibrahim M; Boehringer Ingelheim Middle East & North Africa FZ-Ltd, Dubai, United Arab Emirates.
Lip GYH; Liverpool Centre for Cardiovascular Science, University of Liverpool & Liverpool Heart and Chest Hospital, Liverpool, UK.
Huisman MV; Leiden University Medical Centre, Leiden, The Netherlands.

Int J Cardiol Heart Vasc ; 34: 100763, 2021 Jun.

Article em En | MEDLINE | ID: mdl-33912651

Palavras-chave

Anticoagulant; Atrial fibrillation; NOACs

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article